Metoprolol Succinate Tablet, Extended Release
NDC 67046-0883
Product Information
Metoprolol Succinate is a ANDA-approved product labeled by Coupler Llc. This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. It is supplied as a white tablet, extended release for oral administration. This product entry covers the primary NDC 67046-0883 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
N;25
Code Structure Chart
Product Details
What is NDC 67046-0883?
What are the uses of this product?
What are Active Ingredients of this product?
- METOPROLOL SUCCINATE 25 mg/1 - A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- METOPROLOL SUCCINATE (UNII: TH25PD4CCB)
- METOPROLOL (UNII: GEB06NHM23) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)
- ETHYLCELLULOSE, UNSPECIFIED (UNII: 7Z8S9VYZ4B)
- POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
- HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)
- TRIETHYL CITRATE (UNII: 8Z96QXD6UM)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- POLYDEXTROSE (UNII: VH2XOU12IE)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- TRIACETIN (UNII: XHX3C3X673)
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.